Showing results (31-40 of 639) with videos related to

Sort By:
Pageof 64
Bulletin Du Cancer|February 21, 2004
[Neoadjuvant endocrine therapy for breast cancer: an overview]Julien Domont, Moise Namer, David Khayat, et al.
Bulletin Du Cancer|October 3, 2008
[Femininity and breast cancer, original approach of announcement in oncology]Nathalie Baize, Nicolas Mounier, André Bongain, et al.
Bulletin Du Cancer|August 30, 2008
[Protein kinases C: a new cytoplasmic target]Stéphane Vignot, Jean-Charles Soria, Jean-Philippe Spano, et al.
European Journal of Internal Medicine|May 22, 2002
AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part I: Kaposi's sarcoma, non-Hodgkin's lymphoma, and Hodgkin's lymphomaJean Philippe Spano, Dan Atlan, Jean Luc Breau, et al.
European Journal of Internal Medicine|June 18, 2002
AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part II. Cervical and anal squamous epithelial lesions, lung cancer, testicular germ cell cancers, and skin cancersJean Philippe Spano, Dan Atlan, Jean Luc Breau, et al.
Critical Reviews in Oncology/Hematology|August 19, 2007
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectivesJoseph Gligorov, David Azria, Moise Namer, et al.
Presse Medicale (Paris, France : 1983)|March 1, 2003
[The interest of radiotherapy in cancer of the rectum]Jean-Philippe Spano, Thierry Bouillet, Jean-François Morere, et al.
Frontiers in Oncology|September 12, 2022
POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin-paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinomaSheela Rao, Mark Jones, Jill Bowman, et al.
Melanoma Research|July 18, 2006
An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patientsRoger Mouawad, Claude Soubrane, Olivier Rixe, et al.
Bulletin Du Cancer|December 1, 2005
Proteasome inhibition: a new approach for the treatment of malignanciesJean-Philippe Spano, Jacques-Olivier Bay, Jean-Yves Blay, et al.
Pageof 64